ArticleJournal of medical biochemistry2021
Role of biochemical markers in the monitoring of COVID-19 patients.
Article in Journal of medical biochemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 50 citations in OpenAlex.
- Haematological and Biochemical Parameters of COVID-19 Patients Hospitalised at Selected Central Hospitals in Malawi: A Retrospective Study.Health science reports · 2026Article
- Combining label-free Raman spectroscopy and machine learning to identify early biomarkers of COVID-19 disease severity and mortality.Journal of biomedical optics · 2026Article
- Gender differences in correlation of biochemical parameters with the severity of covid pneumonia and the need for oxygen/mechanical support.Journal of medical biochemistry · 2025Article
- Lifestyle and Biochemical Parameters That May Hamper Immune Responses in Pediatric Patients After Immunization with the BNT162b2 mRNA COVID-19 Vaccine.Diseases (Basel, Switzerland) · 2025Article
- The Impact of Vaccination on COVID-19 Outcomes in Vietnam.Diagnostics (Basel, Switzerland) · 2024Article
- Smoking and Health Profiles of Hypertensive Patients with COVID-19: An Exploratory Study of Key Physiological Markers.Journal of clinical medicine · 2024Article
- Dynamic changes of hematological and hemostatic parameters in COVID-19 hospitalized patients: Potential role as severity biomarkers for the Chilean population.Journal of medical biochemistry · 2024Article
- Evaluation of Biochemical Characteristics in a Retrospective Cohort of COVID-19 Patients.Cureus · 2024Article
- The predictive role of biochemical markers on outcomes of severe COVID-19 patients admitted to intensive care unit.Journal of medical biochemistry · 2023Article
- Mathematical model of aging in COVID-19.Journal of medical biochemistry · 2023Article
- Prognostic values of baseline cortisol levels and neutrophil to lymphocyte ratio in COVID-19.Journal of medical biochemistry · 2023Article
- The utility of serum amyloid A and other acute-phase reactants determination in ambulatory care COVID-19 patients.Journal of medical biochemistry · 2023Article
- Blood prestin levels in COVID-19 patients.Journal of the Chinese Medical Association : JCMA · 2023Article
- Identification of Distinct Clinical Phenotypes of Critically Ill COVID-19 Patients: Results from a Cohort Observational Study.Journal of clinical medicine · 2023Article
- Galectin-3 as an important prognostic marker for COVID-19 severity.Scientific reports · 2023Article
- Diagnostic performance of lactate dehydrogenase (LDH) isoenzymes levels for the severity of COVID-19.Journal of medical biochemistry · 2023Article
- Impact of the seventh day nucleated red blood cell count on mortality in COVID-19 intensive care unit patients: A retrospective case-control study.Journal of medical biochemistry · 2023Article
- Biochemical and hematological findings and risk factors associated with kidney impairment in patients with COVID-19.Journal of medical biochemistry · 2023Article
- Article
- Relationship of inflammatory mediators and sex-related parameters in Jordanian adult men patients with Covid-19.Journal of medical biochemistry · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 is an infectious disease caused by the SARSCoV-2 virus, which has given rise to a global sanitary emergency. The clinical characteristics of COVID-19 are varied and can range from an asymptomatic infection to a mild to severe pneumonia. Recent studies have shown that different laboratory parameters become altered in these patients, and as such are useful as biomarkers to assess the progression of the disease and categorize patients that may present a severe and/or fatal clinical condition. This review analyzes biochemical and immunological markers that become altered in COVID-19 patients and their impact on different organs at a hepatic, cardiac, renal and pancreatic level, as well as markers of inflammation, analyzing their implications in the evolution of the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.